VRDN Viridian Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$19.40
· of 52w range
· above low
· to high
$13.1852w low
$34.2952w high
Market Cap (MRQ)
$2.20B
P/E
-4.8
EPS
$-5.31
Revenue
$71M
your badges
52W Range
$13–$34
Analyst Rating
BUY
Price Target
$37
P/E
-4.8
ROE
-55.4%
Net Profit Margin
-544.1%
Your badge strip is empty — pin a metric anywhere on this page.
VRDN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$19.40
Market Cap (MRQ)
$2.20B
P/E
-4.8
EPS
$-5.31
Revenue
$71M
ROE
-55.4%
52W Range
$13–$34
VRDN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Nov. 13, 2020 | 1-for-15 | Reverse |
| Nov. 7, 2016 | 1-for-15 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$71M2016-12-31 → 2025-12-31
EPS$-5.312020-12-31 → 2023-12-31
Free Cash Flow$-277M2016-12-31 → 2025-12-31
Net margin-544.1%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | VRDN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -4.85Y avg ≈-5.3 | ≈-5.3 | · | · | |
| P/S (TTM) | 30.95Y avg ≈1954.2 | ≈1954.2 | 25.9 | Fair value | |
| P/B (MRQ) | 3.35Y avg ≈3.0 | ≈3.0 | 4.6 | Undervalued | |
| Price / FCF (TTM) | -6.65Y avg ≈-9.2 | ≈-9.2 | · | · | |
| Price / Cash Flow (TTM) | -6.65Y avg ≈-9.2 | ≈-9.2 | · | · | |
| Price / Tangible Book (MRQ) | 3.45Y avg ≈3.0 | ≈3.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | VRDN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -569.7%5Y avg ≈-38167.2% | ≈-38167.2% | -668.2% | Weak | |
| EBITDA Margin (TTM) | -569.0%5Y avg ≈-38094.4% | ≈-38094.4% | -668.2% | Weak | |
| Net Profit Margin (TTM) | -544.1%5Y avg ≈-35118.3% | ≈-35118.3% | -669.0% | Weak | |
| ROA | -41.7%5Y avg ≈-45.0% | ≈-45.0% | -38.7% | In line | |
| ROE | -55.4%5Y avg ≈-46.6% | ≈-46.6% | -59.1% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | VRDN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 16.95Y avg ≈14.8 | ≈14.8 | 8.5 | Strong liquidity | |
| Quick Ratio | 12.45Y avg ≈16.8 | ≈16.8 | 4.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | VRDN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 23359.9%5Y avg ≈4683.2% | ≈4683.2% | · | · | |
| Revenue CAGR 3Y | 242.0%5Y avg ≈51.8% | ≈51.8% | · | · | |
| Revenue CAGR 5Y | 132.2% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | VRDN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.0 | ≈0.0 | 0.1 | Top tier | |
| Revenue / Employee | ≈$281.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
17.4%
Next Report
Nov 03, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-1.05 | $-1.05 | -0.01% |
| March 31, 2026 | May 12, 2026 | $-0.90 | $-1.12 | 19.4% |
| Dec. 31, 2025 | $-1.08 | $-1.09 | 0.96% | |
| Sept. 30, 2025 | $-0.34 | $-1.10 | 69.2% | |
| June 30, 2025 | $-1.00 | $-1.03 | 2.9% | |
| March 31, 2025 | $-0.87 | $-0.99 | 11.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71M | $302.0K | $314.0K | $2M | $3M | $1M | $4M | $8M | $4M | $3M | $3M | $6M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $3M | $2M | $3M | |
| R&D Expense | · | · | · | · | · | · | $35M | $30M | $20M | $14M | $1M | $347.0K | |
| SG&A Expense | $95M | $61M | $95M | $35M | $26M | $13M | $12M | $11M | $11M | $7M | $8M | $7M | |
| Operating Expenses | $434M | $299M | $255M | $136M | $83M | $111M | $46M | $41M | $31M | $20M | $14M | $11M | |
| Operating Income | $-363M | $-299M | $-254M | $-134M | $-80M | $-110M | $-42M | $-33M | $-27M | $-17M | $-11M | $-7M | |
| Interest Expense | · | · | · | $500.0K | · | · | · | · | · | $95.0K | $141.0K | $1M | |
| Interest Income | $27M | $32M | $18M | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $21M | $29M | $17M | $4M | $315.0K | $173.0K | $941.0K | · | · | · | · | · | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Income | $-343M | $-270M | $-238M | $-130M | $-79M | $-111M | $-42M | $-33M | $-27M | $-17M | $-11M | $-8M | |
| EPS (Basic) | · | · | $-5.31 | $-4.05 | $-6.66 | $-31.13 | · | · | · | · | · | · | |
| EPS (Diluted) | · | · | $-5.31 | $-4.05 | $-6.66 | $-31.13 | · | · | · | · | · | · | |
| Shares (Basic) | · | · | 44,755,475 | 32,087,293 | 11,918,712 | 3,557,065 | · | · | · | · | · | · | |
| Shares (Diluted) | · | · | 44,755,475 | 32,087,293 | 11,918,712 | 3,557,065 | · | · | · | · | · | · | |
| EBITDA | $-363M | $-298M | $-254M | $-134M | $-80M | $-110M | $-42M | $-33M | · | $-12M | · | $-7M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $875M | $718M | $477M | $425M | $197M | $128M | $27M | $33M | $47M | $22M | $21M | $5M | |
| Short-term Investments | · | · | · | · | $155M | $82M | $2M | $30M | $0 | · | · | · | |
| Receivables | · | · | · | · | · | · | $108.0K | $24.0K | $1M | $20.0K | $394.0K | $1M | |
| Inventory | · | · | · | · | · | · | · | · | · | $64.0K | $187.0K | $179.0K | |
| Prepaid Expense | $20M | $21M | $9M | $7M | $3M | $2M | $3M | $3M | $3M | $2M | $321.0K | $399.0K | |
| Current Assets | $894M | $738M | $486M | $431M | $200M | $130M | $30M | $65M | $52M | $24M | $12M | $7M | |
| PP&E (Net) | $1M | $1M | $2M | $1M | $375.0K | $309.0K | $523.0K | $727.0K | $563.0K | $625.0K | $1M | $1M | |
| PP&E (Gross) | $2M | $3M | $3M | $3M | $2M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $739.0K | $555.0K | |
| Intangibles | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $501.0K | $604.0K | $982.0K | $1M | $1.0K | $0 | $50.0K | $50.0K | $258.0K | · | · | |
| Total Assets | $899M | $742M | $490M | $435M | $204M | $131M | $30M | $66M | $52M | $25M | $13M | $8M | |
| Accounts Payable | $9M | $2M | $2M | $14M | $2M | $670.0K | $1M | $571.0K | $906.0K | $1M | $242.0K | $255.0K | |
| Accrued Liabilities | $62M | $46M | $24M | $19M | $11M | $10M | $5M | $4M | $3M | $4M | $1M | $361.0K | |
| Short-term Debt | · | · | · | · | · | $0 | $4M | $2M | $0 | $2M | · | · | |
| Current Liabilities | $71M | $48M | $27M | $33M | $14M | $11M | $10M | $7M | $4M | $7M | $2M | $2M | |
| Capital Leases | $2M | $2M | $1M | $1M | $1M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $989.0K | $1M | $1M | $43.0K | $0 | $66.0K | $152.0K | $0 | $24.0K | $109.0K | |
| Total Liabilities | $177M | $71M | $48M | $40M | $16M | $11M | $15M | $15M | $14M | $10M | · | · | |
| Long-term Debt | · | $21M | $20M | $5M | $0 | · | $8M | $10M | $10M | · | · | · | |
| Total Debt | · | $21M | · | · | · | $0 | $4M | $2M | · | · | · | · | |
| Common Stock | $1M | $810.0K | $540.0K | $414.0K | $239.0K | $42.0K | $23.0K | $308.0K | $226.0K | $8.0K | $7.0K | $38.0K | |
| Paid-in Capital | $1.93B | $1.48B | $961M | $741M | $412M | $218M | $184M | $177M | $132M | $5M | $28M | $13M | |
| Retained Earnings | $-1.34B | $-996M | $-726M | $-488M | $-358M | $-279M | $-168M | $-126M | $-94M | $-67M | $-18M | $-7M | |
| AOCI | $447.0K | $-10.0K | $338.0K | $-390.0K | $-157.0K | $-8.0K | $0 | $-3.0K | $0 | · | · | · | |
| Stockholders' Equity | $722M | $672M | $442M | $395M | $188M | $120M | $16M | $51M | $39M | $-62M | $-45M | $6M | |
| Liabilities + Equity | $899M | $742M | $490M | $435M | $204M | $131M | $30M | $66M | $52M | $25M | $13M | $8M | |
| Shares Outstanding | 101,826,500 | 80,994,046 | 53,986,112 | 41,305,947 | 23,924,004 | 4,231,135 | 2,324,126 | 30,839,463 | 22,568,006 | 833,744 | 601,667 | 3,782,629 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $460.0K | $540.0K | $522.0K | $255.0K | $120.0K | $239.0K | $288.0K | $281.0K | $308.0K | $341.0K | $184.0K | $144.0K | |
| Stock-based Comp | $44M | $42M | $67M | $20M | $14M | $4M | $4M | $4M | $2M | $198.0K | $3M | $4M | |
| Restructuring | · | · | · | · | · | $300.0K | $2M | · | · | · | · | · | |
| Other Non-cash | $21M | $-5M | $-14M | $16M | $10M | $77M | $2M | $2M | · | $3M | · | $1M | |
| Operating Cash Flow | $-276M | $-232M | $-184M | $-94M | $-55M | $-30M | $-36M | $-27M | $-28M | $-15M | $-7M | $-2M | |
| CapEx | $495.0K | $511.0K | $898.0K | $797.0K | $338.0K | $42.0K | $84.0K | $445.0K | $246.0K | $250.0K | $123.0K | $266.0K | |
| Investing Cash Flow | $-38M | $-229M | $-94M | $-115M | $-74M | $-50M | $28M | $-30M | $1M | $-250.0K | $-95.0K | $-274.0K | |
| Debt Issued | $29M | $0 | $15M | $5M | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $29M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $63M | $70M | $15M | $292M | $114M | $0 | $2M | $45M | · | · | $13M | $7M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $2.0K | · | · | |
| Net Stock Activity | $63M | $454M | $125M | $292M | $114M | · | $2M | · | · | $-2.0K | · | $7M | |
| Financing Cash Flow | $427M | $458M | $226M | $322M | $125M | $101M | $70.0K | $42M | $52M | $16M | $13M | $7M | |
| Net Change in Cash | $113M | $-3M | $-53M | $113M | $-4M | $21M | $-8M | $-15M | $25M | · | · | · | |
| Free Cash Flow | $-277M | $-233M | $-185M | $-95M | $-55M | $-30M | $-36M | $-27M | · | $-7M | · | $-2M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -512.9% | -99018.2% | -81035.0% | -7579.2% | -2690.8% | -10512.4% | -941.0% | -394.5% | · | -374.8% | · | -105.9% | |
| Net Margin | -483.6% | -89387.1% | -75711.5% | -7329.2% | -2680.2% | -10544.3% | -938.6% | -390.0% | · | -379.8% | · | -121.7% | |
| EBITDA Margin | -512.3% | -98839.4% | -80868.8% | -7564.8% | -2686.7% | -10489.6% | -934.6% | -391.2% | · | -369.2% | · | -103.7% | |
| ROA | -41.7% | -43.8% | -51.4% | -40.7% | -47.4% | -137.1% | -86.9% | -55.1% | · | -147.7% | · | -134.2% | |
| ROE | -55.4% | -39.1% | -65.5% | -32.3% | -40.5% | -156.9% | -215.2% | -58.4% | · | 55.6% | · | 88.2% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.6 | 15.4 | 18.3 | 12.9 | 14.7 | 12.1 | 2.9 | 9.7 | · | 0.9 | · | 3.4 | |
| Quick Ratio | 12.4 | 15.0 | 17.9 | 12.7 | 25.8 | 19.6 | 2.8 | 9.3 | · | 0.8 | · | 3.1 | |
| Debt / Equity | · | 0.0 | · | · | · | 0.0 | 0.3 | 0.0 | · | · | · | · | |
| LT Debt / Equity | · | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | -268.6 | · | · | · | · | · | -131.7 | · | -6.7 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | · | 0.4 | · | 1.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 20.3 | · | 12.1 | |
| Receivables Turnover | · | · | · | · | · | · | 67.6 | 11.3 | · | 7.3 | · | 6.2 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.09 | $8.29 | $8.19 | $9.56 | $7.85 | $28.37 | $0.45 | $1.66 | · | $-0.44 | · | $1.58 | |
| Revenue / Share | · | · | $0.01 | $0.06 | $0.25 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | $-4.12 | $-2.92 | $-4.58 | · | · | · | · | · | · | · | |
| Cash / Share | $8.59 | $8.86 | $8.84 | $10.28 | $8.23 | $30.16 | $0.77 | $1.06 | · | $4.50 | · | $1.35 | |
| EPS (TTM) | $-4.05 | $-4.05 | $-5.31 | $-4.05 | $-6.66 | $-31.13 | · | · | · | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 23359.9% | -3.8% | -82.3% | -40.2% | 182.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 242.0% | -53.3% | -33.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 132.2% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $71M | $302.0K | $314.0K | $2M | $3M | $1M | $4M | $8M | $4M | $3M | $3M | $6M | |
| Net Income TTM | $-343M | $-270M | $-238M | $-130M | $-79M | $-111M | $-42M | $-33M | $-27M | $-17M | $-11M | $-8M | |
| Market Cap | $3.17B | $1.55B | $1.18B | $1.21B | $473M | $70M | $251M | $1.40B | · | $56M | · | $2.16B | |
| Enterprise Value | · | $856M | · | · | · | $-140M | $226M | $1.34B | · | · | · | · | |
| P/E | -7.7 | -4.7 | -4.1 | -7.2 | -3.0 | -0.5 | · | · | · | · | · | · | |
| P/S | 44.7 | 5141.2 | 3744.6 | 680.9 | 159.6 | 66.3 | 56.3 | 167.1 | · | 16.0 | · | 333.4 | |
| P/B | 4.4 | 2.3 | 2.7 | 3.1 | 2.5 | 0.6 | 15.9 | 27.3 | · | -171.1 | · | 360.8 | |
| P / Tangible Book | 4.4 | 2.3 | 2.7 | 3.1 | 2.5 | 0.6 | · | · | · | · | · | · | |
| P / Cash Flow | -11.5 | -6.7 | -6.4 | -12.9 | -8.7 | -2.3 | -7.0 | -52.2 | · | -7.7 | · | -976.9 | |
| P / FCF | -11.4 | -6.7 | -6.4 | -12.7 | -8.6 | -2.3 | -6.9 | -51.4 | · | -7.7 | · | -872.0 | |
| EV / EBITDA | · | -2.9 | · | · | · | 1.3 | -5.4 | -40.9 | · | · | · | · | |
| EV / FCF | · | -3.7 | · | · | · | 4.7 | -6.3 | -49.2 | · | · | · | · | |
| EV / Revenue | · | 2833.2 | · | · | · | -133.1 | 50.7 | 160.0 | · | · | · | · | |
| Earnings Yield | -13.0% | -21.1% | -24.4% | -13.9% | -33.7% | -189.2% | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $284.0K | $141.0K | $132.0K | $71M | $75.0K | $72.0K | $72.0K | $86.0K | $72.0K | $72.0K | $72.0K | $72.0K | $98.0K | $1M | $256.0K | $216.0K | |
| SG&A Expense | $55M | $39M | $34M | $24M | $20M | $17M | $16M | $14M | $16M | $15M | $21M | $19M | $22M | $9M | $8M | $8M | |
| Operating Expenses | $127M | $116M | $123M | $111M | $107M | $94M | $88M | $84M | $72M | $56M | $51M | $59M | $73M | $31M | $30M | $26M | |
| Operating Income | $-126M | $-116M | $-123M | $-40M | $-107M | $-94M | $-87M | $-83M | $-72M | $-56M | $-51M | $-59M | $-72M | $-30M | $-30M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $200.0K | $200.0K | $200.0K | $200.0K | $0 | |
| Interest Income | $8M | $8M | $8M | $6M | $7M | $8M | $9M | $8M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-851.0K | $11M | $2M | $5M | $6M | $7M | $8M | $7M | $7M | $7M | $4M | $4M | $4M | $880.0K | $73.0K | $196.0K | |
| Net Income | $-127M | $-105M | $-120M | $-35M | $-101M | $-87M | $-80M | $-77M | $-65M | $-49M | $-48M | $-55M | $-68M | $-29M | $-29M | $-26M | |
| EPS (Basic) | · | · | · | · | · | · | · | $-1.15 | $-1.02 | $-0.79 | $-1.09 | $-1.27 | $-1.61 | $-0.86 | $-1.06 | $-0.98 | |
| EPS (Diluted) | · | · | · | · | · | · | · | $-1.15 | $-1.02 | $-0.79 | $-1.09 | $-1.27 | $-1.61 | $-0.86 | $-1.06 | $-0.98 | |
| Shares (Basic) | · | · | · | · | · | · | · | 66,420,063 | 63,854,514 | 61,099,038 | 43,654,577 | 43,253,457 | 42,242,309 | 33,742,076 | 27,762,257 | 26,126,092 | |
| Shares (Diluted) | · | · | · | · | 81,593,463 | 81,344,134 | · | 66,420,063 | 63,854,514 | 61,099,038 | 43,654,577 | 43,253,457 | 42,242,309 | 33,742,076 | 27,762,257 | 26,126,092 | |
| EBITDA | · | $-116M | · | $-40M | $-107M | $-94M | · | $-83M | $-72M | $-56M | $-51M | $-59M | $-72M | $-30M | $-30M | $-26M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $982M | $762M | $875M | $491M | $563M | $637M | · | $753M | $571M | $613M | $313M | $334M | $374M | $431M | $161M | $175M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $145M | |
| Prepaid Expense | $25M | $23M | $20M | $11M | $15M | $21M | $21M | $14M | $10M | $14M | $11M | $12M | $9M | $6M | $4M | $3M | |
| Current Assets | $1.08B | $785M | $894M | $572M | $579M | $657M | $738M | $767M | $582M | $627M | $324M | $346M | $383M | $437M | $166M | $179M | |
| PP&E (Net) | $3M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $825.0K | $749.0K | $691.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $3M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1M | $888.0K | $2M | $2M | $506.0K | $489.0K | $501.0K | $853.0K | $659.0K | $555.0K | $1M | $1M | $982.0K | $1M | $2M | $2M | |
| Total Assets | $1.10B | $789M | $899M | $577M | $582M | $661M | $742M | $772M | $586M | $630M | $329M | $351M | $387M | $441M | $170M | $183M | |
| Accounts Payable | $9M | $13M | $9M | $10M | $9M | $4M | $2M | $6M | $3M | $3M | $4M | $4M | $8M | $12M | $4M | $3M | |
| Accrued Liabilities | $55M | $38M | $62M | $41M | $35M | $30M | $46M | $35M | $30M | $23M | $19M | $24M | $21M | $13M | $17M | $12M | |
| Current Liabilities | $64M | $52M | $71M | $51M | $53M | $34M | $48M | $41M | $37M | $26M | $23M | $29M | $30M | $25M | $21M | $14M | |
| Capital Leases | · | · | $2M | $2M | $2M | $2M | · | $2M | $2M | $900.0K | $1M | $1M | $1M | $800.0K | $900.0K | $1M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $896.0K | $1M | $2M | $1M | $813.0K | $938.0K | $1M | |
| Total Liabilities | $435M | $153M | $177M | $74M | $67M | $57M | $71M | $64M | $56M | $48M | $45M | $36M | $36M | $32M | $28M | $17M | |
| Long-term Debt | · | · | · | · | $21M | · | · | · | $20M | $20M | $20M | $5M | $5M | $5M | $5M | · | |
| Total Debt | · | · | · | $21M | $21M | $21M | · | $21M | $20M | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $1M | $822.0K | $817.0K | $816.0K | $810.0K | $792.0K | $639.0K | $638.0K | $437.0K | $436.0K | $431.0K | $402.0K | $285.0K | $272.0K | |
| Paid-in Capital | $2.13B | $1.95B | $1.93B | $1.53B | $1.51B | $1.50B | $1.48B | $1.43B | $1.17B | $1.16B | $807M | $792M | $772M | $710M | $453M | $439M | |
| Retained Earnings | $-1.57B | $-1.44B | $-1.34B | $-1.22B | $-1.18B | $-1.08B | $-996M | $-916M | $-839M | $-774M | $-659M | $-611M | $-556M | $-442M | $-413M | $-384M | |
| AOCI | $-1M | $-558.0K | $447.0K | $363.0K | $69.0K | $245.0K | $-10.0K | $932.0K | $-543.0K | $-367.0K | $-64.0K | $-173.0K | $-174.0K | $-940.0K | $-1M | $-935.0K | |
| Stockholders' Equity | $662M | $636M | $722M | $503M | $515M | $604M | $672M | $707M | $529M | $583M | $284M | $316M | $351M | $409M | $142M | $167M | |
| Liabilities + Equity | $1.10B | $789M | $899M | $577M | $582M | $661M | $742M | $772M | $586M | $630M | $329M | $351M | $387M | $441M | $170M | $183M | |
| Shares Outstanding | 113,238,218 | 102,458,094 | 101,826,500 | 82,229,158 | 81,651,186 | 81,589,427 | 80,994,046 | 79,181,445 | 63,879,675 | 63,798,536 | 43,700,989 | 43,562,208 | 43,055,318 | 40,244,355 | 28,463,980 | 23,924,004 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $117.0K | $121.0K | $120.0K | $110.0K | $113.0K | $117.0K | $123.0K | $130.0K | $142.0K | $145.0K | $135.0K | $132.0K | $105.0K | $62.0K | $57.0K | $40.0K | |
| Stock-based Comp | $17M | $13M | $12M | $11M | $11M | $10M | $9M | $9M | $12M | $13M | $14M | $12M | $15M | $5M | $5M | $5M | |
| Other Non-cash | · | $-28M | · | · | · | $-16M | · | · | · | $-10M | · | · | $-9M | · | · | $-48.0K | |
| Operating Cash Flow | $-105M | $-120M | $-24M | $-85M | $-75M | $-93M | $-73M | $-68M | $-46M | $-45M | $-39M | $-45M | $-62M | $-21M | $-18M | $-21M | |
| CapEx | $1M | $23.0K | $240.0K | $127.0K | $42.0K | $86.0K | $114.0K | $293.0K | $104.0K | $0 | $404.0K | $331.0K | $115.0K | $95.0K | $292.0K | $179.0K | |
| Investing Cash Flow | $-231M | $77M | $-339M | $126M | $76M | $100M | $-63M | $-85M | $62M | $-143M | $48M | $41M | $-13M | $43M | $14M | $9M | |
| Debt Issued | · | · | · | · | · | · | $0 | · | · | · | $15M | · | · | $0 | · | · | |
| Stock Issued | $0 | $0 | $48M | $10M | $1.0K | $5M | $34M | $-150M | $0 | $186M | $0 | $0 | $0 | $267M | · | · | |
| Net Stock Activity | · | $0 | · | · | · | · | · | · | · | $186M | · | · | · | · | · | · | |
| Financing Cash Flow | $325M | $6M | $406M | $11M | $764.0K | $9M | $36M | $245M | $108.0K | $177M | $15M | $3M | $8M | $291M | $5M | $738.0K | |
| Net Change in Cash | $-11M | $-36M | $43M | $52M | $1M | $17M | $-101M | $93M | $16M | $-11M | $25M | $-1M | $-67M | $313M | $435.0K | $-11M | |
| Free Cash Flow | · | $-120M | · | · | · | $-93M | · | · | · | $-45M | · | · | $-62M | · | · | $-21M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -82389.4% | · | -56.7% | -142356.0% | -130369.4% | · | -97069.8% | -100259.7% | -77634.7% | -71144.4% | -82326.4% | -73952.0% | -2492.5% | -11548.4% | -11985.6% | |
| Net Margin | · | -74397.9% | · | -49.0% | -134313.3% | -120711.1% | · | -89173.3% | -90268.1% | -67419.4% | -66194.4% | -76476.4% | -69541.8% | -2418.8% | -11519.9% | -11894.9% | |
| EBITDA Margin | · | -82303.5% | · | -56.7% | -142356.0% | -130206.9% | · | -97069.8% | -100259.7% | -77433.3% | -71144.4% | -82326.4% | -73844.9% | -2492.5% | -11548.4% | -11967.1% | |
| ROA | · | -14.5% | · | -5.1% | -17.2% | -13.5% | · | -13.9% | -13.9% | -9.6% | -12.4% | -21.1% | -23.9% | -8.7% | -20.5% | -16.8% | |
| ROE | · | -16.9% | · | -5.7% | -19.3% | -14.6% | · | -15.5% | -15.4% | -10.4% | -13.8% | -24.1% | -26.4% | -9.4% | -24.5% | -18.9% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 15.1 | · | 11.3 | 11.0 | 19.5 | · | 18.6 | 15.8 | 24.0 | 13.9 | 12.1 | 12.9 | 17.3 | 7.8 | 12.5 | |
| Quick Ratio | · | 14.7 | · | 9.7 | 10.7 | 18.9 | · | 18.2 | 15.5 | 23.5 | 13.5 | 11.7 | 12.6 | 17.1 | 7.5 | 22.2 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -296.4 | -362.4 | -148.9 | -147.8 | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $6.21 | · | $6.12 | $6.31 | $7.41 | · | $8.94 | $8.29 | $9.13 | $6.49 | $7.25 | $8.14 | $10.16 | $4.99 | $6.97 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.01 | $0.01 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.74 | · | · | $-1.47 | · | · | $-0.81 | |
| Cash / Share | · | $7.44 | · | $5.97 | $6.90 | $7.80 | · | $9.51 | $8.94 | $9.61 | $7.16 | $7.67 | $8.68 | $10.72 | $5.66 | $7.33 | |
| EPS (TTM) | $-4.05 | · | · | · | · | · | · | · | · | · | · | · | · | $-3.19 | $-3.58 | $-4.73 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $71M | $71M | · | $71M | $305.0K | $302.0K | · | $302.0K | $288.0K | $288.0K | $347.0K | $1M | $2M | $2M | $894.0K | $2M | |
| Net Income TTM | $-367M | $-361M | · | $-302M | $-344M | $-308M | · | $-257M | $-228M | $-218M | $-217M | $-198M | $-172M | $-113M | $-98M | $-87M | |
| Market Cap | · | $2.00B | · | $1.77B | $1.14B | $1.10B | · | $1.80B | $831M | $1.12B | $670M | $1.04B | $1.10B | $825M | $329M | $442M | |
| Enterprise Value | · | · | · | $1.30B | $599M | $484M | · | $1.07B | $280M | · | · | · | · | · | · | · | |
| P/E | -4.5 | · | · | · | · | · | · | · | · | · | · | · | · | -6.4 | -3.2 | -3.9 | |
| P/S | · | 28.3 | · | 25.1 | 3742.6 | 3641.8 | · | 5964.8 | 2885.7 | 3878.9 | 1931.9 | 705.0 | 662.2 | 438.8 | 368.4 | 256.0 | |
| P/B | 3.1 | 3.2 | · | 3.5 | 2.2 | 1.8 | · | 2.5 | 1.6 | 1.9 | 2.4 | 3.3 | 3.1 | 2.0 | 2.3 | 2.7 | |
| P / Tangible Book | 3.2 | 3.2 | · | 3.5 | 2.2 | 1.8 | · | 2.5 | 1.6 | 1.9 | 2.4 | 3.3 | 3.1 | 2.0 | 2.3 | 2.7 | |
| P / Cash Flow | · | -16.7 | · | · | · | -11.9 | · | · | · | -24.7 | · | · | -17.7 | · | · | -21.0 | |
| EV / Revenue | · | · | · | 18.4 | 1963.5 | 1602.4 | · | 3538.7 | 972.7 | · | · | · | · | · | · | · | |
| Earnings Yield | -22.1% | · | · | · | · | · | · | · | · | · | · | · | · | -15.6% | -30.9% | -25.6% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $71M | $302.0K | $314.0K | $2M | $3M |
| Operating Margin % | -512.9% | -99018.2% | -81035.0% | -7579.2% | -2690.8% |
| Net Income | $-343M | $-270M | $-238M | $-130M | $-79M |
| Diluted EPS | · | · | $-5.31 | $-4.05 | $-6.66 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | 0.0 | · | · | · |
| Current Ratio | 12.6 | 15.4 | 18.3 | 12.9 | 14.7 |
| Quick Ratio | 12.4 | 15.0 | 17.9 | 12.7 | 25.8 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-277M | $-233M | $-185M | $-95M | $-55M |
Institutional owners (13F) 226 filers · $2.6B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
226
Value held
$2.6B
New positions
51
Exited positions
51
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 51 (-4 vs prior Q) | 51 (+4 vs prior Q) | 93 (+12 vs prior Q) | 52 (-11 vs prior Q) | +22.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $305,029,074 | 16,604,740 | 11.87% | Shares |
| VANGUARD GROUP INC | $174,649,921 | 5,612,144 | 6.79% | Shares |
| BlackRock, Inc. | $157,090,835 | 8,551,488 | 6.11% | Shares |
| Bellevue Group AG | $123,665,169 | 6,731,909 | 4.81% | Shares |
| Paradigm Biocapital Advisors LP | $123,515,986 | 6,723,788 | 4.81% | Shares |
| Kynam Capital Management, LP | $118,557,720 | 6,453,877 | 4.61% | Shares |
| STATE STREET CORP | $112,515,809 | 6,124,976 | 4.38% | Shares |
| Fairmount Funds Management LLC | $93,520,347 | 5,090,928 | 3.64% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $84,076,918 | 4,576,860 | 3.27% | Shares |
| Deep Track Capital, LP | $65,998,634 | 3,592,740 | 2.57% | Shares |
| Venrock Adviser, LLC | $59,847,935 | 3,257,917 | 2.33% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $57,468,009 | 3,128,362 | 2.24% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $50,569,432 | 2,752,827 | 1.97% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $45,968,039 | 2,501,869 | 1.79% | Shares |
| Avoro Capital Advisors LLC | $45,925,000 | 2,500,000 | 1.79% | Shares |
| BAKER BROS. ADVISORS LP | $43,776,169 | 2,383,025 | 1.70% | Shares |
| Point72 Asset Management, L.P. | $43,044,731 | 2,343,208 | 1.67% | Shares |
| Caligan Partners LP | $40,303,431 | 2,193,981 | 1.57% | Shares |
| NOVO HOLDINGS A/S | $39,219,950 | 2,135,000 | 1.53% | Shares |
| TANG CAPITAL MANAGEMENT LLC | $32,930,540 | 1,792,626 | 1.28% | Shares |
| Fisher Asset Management, LLC | $32,163,113 | 1,750,850 | 1.25% | Shares |
| Candriam S.C.A. | $31,340,230 | 1,707,698 | 1.22% | Shares |
| GOLDMAN SACHS GROUP INC | $31,069,254 | 1,691,304 | 1.21% | Shares |
| First Turn Management, LLC | $30,677,900 | 1,670,000 | 1.19% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $29,607,274 | 1,611,521 | 1.15% | Shares |
| ALLIANCEBERNSTEIN L.P. | $27,220,459 | 1,391,639 | 1.06% | Shares |
| UBS Group AG | $26,247,845 | 1,428,843 | 1.02% | Shares |
| Parkman Healthcare Partners LLC | $25,306,071 | 1,377,576 | 0.98% | Shares |
| Balyasny Asset Management L.P. | $23,511,010 | 1,279,859 | 0.91% | Shares |
| D. E. Shaw & Co., Inc. | $21,717,418 | 1,182,222 | 0.84% | Shares |
| RICE HALL JAMES & ASSOCIATES, LLC | $21,601,393 | 1,175,906 | 0.84% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $20,435,027 | 1,112,413 | 0.79% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $18,592,975 | 1,012,138 | 0.72% | Shares |
| Elmind Capital, LP | $18,093,182 | 984,931 | 0.70% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $17,375,111 | 888,298 | 0.68% | Shares |
| BANK OF AMERICA CORP /DE/ | $17,347,618 | 944,345 | 0.67% | Shares |
| NORTHERN TRUST CORP | $15,862,330 | 863,491 | 0.62% | Shares |
| Eversept Partners, LP | $15,268,079 | 831,142 | 0.59% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $14,972,046 | 815,027 | 0.58% | Shares |
| Schonfeld Strategic Advisors LLC | $14,576,741 | 793,508 | 0.57% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $14,119,182 | 768,600 | 0.55% | Shares |
| MORGAN STANLEY | $13,388,384 | 728,817 | 0.52% | Shares |
| Woodline Partners LP | $12,876,066 | 700,929 | 0.50% | Shares |
| JPMORGAN CHASE & CO | $12,106,209 | 639,929 | 0.47% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $12,079,892 | 657,588 | 0.47% | Shares |
| PERCEPTIVE ADVISORS LLC | $10,690,973 | 581,980 | 0.42% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $9,939,235 | 541,058 | 0.39% | Shares |
| EMERALD ADVISERS, LLC | $9,870,715 | 537,328 | 0.38% | Shares |
| DEUTSCHE BANK AG\ | $8,870,414 | 482,875 | 0.35% | Shares |
| ALGERT GLOBAL LLC | $8,858,694 | 482,237 | 0.34% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC ×9 filings | May 13, 2026 | 14.04% | Amendment | Passive investment | SEC |
| ATLAS VENTURE FUND VII, L.P., ATLAS VENTURE ASSOCIATES VII, L.P., ATLAS VENTURE ASSOCIATES VII, INC. ×2 filings | June 14, 2023 | · | Initial filing | · | SEC |
| / Boulder Ventures V, L.P., / BV Partners V, L.L.C., / Boulder Ventures VI, L.P., / BV Partners VI, L.L.C., / Kyle Lefkoff, / Jonathan L. Perl, / Peter A. Roshko | Aug. 16, 2017 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | March 7, 2017 | · | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Feb. 24, 2017 | · | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 40 insiders · 19 officers · 24 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Stephen F. Mahoney | President and CEO | March 3, 2026 F | 33,349 | 0 | 0 | $0 |
| Scott Dunseth Myers | Chief Executive Officer | April 12, 2023 P | 259,500 | 0 | 0 | $0 |
| Jonathan Violin | Chief Executive Officer | Feb. 2, 2023 M | 480,905 | 0 | 0 | $0 |
| William Stuart Marshall | President & CEO | Feb. 12, 2020 A | 265,646 | 0 | 0 | $0 |
| Samuel D Riccitelli | President & CEO | Oct. 31, 2016 M | 571,370 | 0 | 0 | $0 |
| Seth Harmon | Chief Financial Officer | March 3, 2026 F | 7,850 | 0 | 0 | $0 |
| Kristian Humer | CFO and CBO | Feb. 8, 2023 A | · | 0 | 0 | $0 |
| Jason A. Leverone | Chief Financial Officer | Jan. 18, 2021 A | 48,829 | 0 | 0 | $0 |
| Tamara A Seymour | CFO, Secretary, Treasurer | Oct. 31, 2016 M | 106,447 | 0 | 0 | $0 |
| Thomas W. Beetham | Chief Operating Officer | March 3, 2026 F | 13,361 | 0 | 0 | $0 |
| Carrie Melvin | COO | Feb. 8, 2023 A | · | 0 | 0 | $0 |
| Jennifer Tousignant | Chief Legal Officer | Aug. 19, 2026 M | 0 | 0 | 3 | $-418,990 |
| Radhika Tripuraneni | Chief Medical Officer | Aug. 14, 2026 M | 40,000 | 0 | 0 | $0 |
| Thomas Ciulla | Chief Medical Officer | Feb. 5, 2024 A | · | 0 | 0 | $0 |
| Lara Meisner | Chief Legal Officer | June 16, 2023 M | 29,971 | 0 | 0 | $0 |
| Barrett Katz | Chief Medical Officer | Feb. 8, 2023 A | 0 | 0 | 0 | $0 |
| Diana Escolar | Chief Medical Officer | Feb. 12, 2020 A | · | 0 | 0 | $0 |
| Adam Scott Levy | Chief Business Officer | Feb. 6, 2019 A | 10,540 | 0 | 0 | $0 |
| Paul D Rubin | EVP, Research & Development | Feb. 6, 2019 A | · | 0 | 0 | $0 |
| Sarah Gheuens | Director | July 1, 2026 A | · | 0 | 0 | $0 |
| Tomas Kiselak | Director | July 1, 2026 A | · | 0 | 0 | $0 |
| Christopher W. Cain | Director | July 1, 2026 A | · | 0 | 0 | $0 |
| Jennifer K. Moses | Director | July 1, 2026 A | · | 0 | 0 | $0 |
| Jeffrey Robert Ajer | Director | July 1, 2026 A | · | 0 | 0 | $0 |
| Arlene Morris | Director | July 1, 2026 A | · | 0 | 0 | $0 |
| Peter Harwin | Director | June 26, 2024 A | · | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Director | Feb. 4, 2021 A | · | 0 | 0 | $0 |
| Joseph L Turner | Director | Feb. 4, 2021 A | · | 0 | 0 | $0 |
| Thomas E. Hughes | Director | May 21, 2020 A | 12,827 | 0 | 0 | $0 |
| Christopher Bowden | Director | May 21, 2020 A | · | 0 | 0 | $0 |
| Kevin Koch | Director | May 21, 2020 A | · | 0 | 0 | $0 |
| Bruce Booth | Director | June 27, 2018 A | 1,351,090 | 0 | 0 | $0 |
| John W Creecy | Director | June 28, 2017 A | · | 0 | 0 | $0 |
| Kyle Lefkoff | Director | June 28, 2017 A | 463,473 | 0 | 0 | $0 |
| LEBOW BENNETT S | Director | Feb. 13, 2017 M | 280,600 | 0 | 0 | $0 |
| David A Gonyer | Director | Feb. 8, 2017 M | 1,899 | 0 | 0 | $0 |
| Robin L Smith | Director | Feb. 3, 2017 M | 1,900 | 0 | 0 | $0 |
| Douglas A Schuling | Director | June 15, 2016 A | 10,500 | 0 | 0 | $0 |
| Logos Global Master Fund LP | 10% owner | Nov. 13, 2020 P | 550,000 | 0 | 0 | $0 |
| Lee M. Rauch | · | Jan. 18, 2021 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 37 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.78% | 19,010 NS | July 31, 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.51% | 132,937 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.48% | 306,726 SH | Sept. 11, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.14% | 1,816 NS | July 31, 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.14% | 93,739 NS | July 31, 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.09% | 70,285 SH | Aug. 19, 2026 | Daily |
| FFSM · FIDELITY COVINGTON TRUST | 0.08% | 62,894 NS | July 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 25,498 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.07% | 2,305,679 SH | Sept. 11, 2026 | Daily |
| ESML · iShares Trust | 0.06% | 72,325 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.05% | 43,243 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.05% | 519,684 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.05% | 59,099 SH | Oct. 1, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.04% | 331,726 NS | July 31, 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.03% | 8,493 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.02% | 10,323 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 36,733 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 1,130,108 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.02% | 232,698 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.02% | 5,361 SH | Sept. 11, 2026 | Daily |
| TILT · FlexShares Trust | 0.02% | 19,750 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.01% | 89,350 SH | Sept. 11, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.01% | 3,037 NS | July 31, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 9,567 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.01% | 245,102 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 13,475 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 5,737 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 25,458 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 141,136 SH | Sept. 11, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 26,238 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 19,585 SH | Sept. 4, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3,338,398 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,732 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 757,567 SH | Sept. 11, 2026 | Daily |
| ISCB · iShares Trust | · | 4,277 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 13,384 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 5,861 SH | Sept. 4, 2026 | Daily |
VRDN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 23 analysts
BUY
Median target
$36.50
+88.1%
8 34.8%
Strong Buy
14 60.9%
Buy
1 4.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
16 analysts · 2026-09-29Mean target $36.75 +89.4%
← Below all targets
Current price $19.40
Low$22.00
Mean$36.75
High$50.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | · |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | · |
| VERA | · | -10.9 | · | · | -55.9% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026